South Korea - Diabetes Medicine Use
Since 2014, South Korea Diabetes Medicine Use increased 1.2% year on year. In 2019, the country was ranked number 18 comparing other countries in Diabetes Medicine Use with 64.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day. South Korea is overtaken by Italy, which was number 17 at 64.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Luxembourg with 63 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Finland ranked the highest with 97.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, +1.6% compared to 2018. Czech Republic, Canada and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Canada witnessed the best average annual growth at +9.6% per year, while Chile was the worst growing country at -1.6% per year.
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 64.60 |
| 2018 | 65.20 |
| 2017 | 63.10 |
| 2016 | 60.30 |
| 2015 | 61.70 |
How does South Korea rank in Diabetes Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Finland
|
97 | 2019 | +1.6 % | +2.0 % | View data | |
| 2 |
#2
Czech Republic
|
93 | 2019 | +2.8 % | +1.9 % | View data | |
| 17 |
#17
Italy
|
65 | 2019 | +2.5 % | +0.8 % | View data | |
| 18 |
#18
South Korea
|
65 | 2019 | -0.9 % | +1.2 % | View data | |
| 19 |
#19
Luxembourg
|
63 | 2019 | -0.3 % | -0.5 % | View data | |